Challenges: 

Like many biotech companies, ElevateBio didn’t have the early-stage resources needed to implement effective digital marketing and brand strategies. They needed to effectively translate advanced biotech concepts, R&D accomplishments, and cGMP standards and technical content into a cohesive and engaging story to support their internal growth goals, brand awareness, and market presence.

Solutions: 

Agency39A began by conducting a digital maturity assessment to define ElevateBio's brand, digital, content, and organizational needs. Through design sprints, we engaged the leadership and scientific teams to develop concepts and future-state visions. We crafted a brand strategy for future growth, mergers, and acquisitions, and a digital strategy encompassing content, brand identity, user experience, and digital marketing tactics. We navigated regulatory hurdles for Biotech advertising on digital platforms and launched multiple marketing campaigns, rapidly growing their audience on Instagram, Twitter, and LinkedIn. Additionally, we developed brand and digital strategies, marketing platforms, and robust websites for their acquired brands and mergers.

Results: 

Agency39A crafted a comprehensive brand strategy playbook with brand and product naming blueprints for ElevateBio. We developed and curated visual and verbal content for BoD presentations, IPO, web and digital marketing, social media, and conference support. Our Biotech Google Ad campaigns navigated regulatory hurdles with ease. Our efforts resulted in a 78% increase in LinkedIn followers, establishing ElevateBio as a micro-influencer, and an 84.7% increase in Twitter followers. We drove ElevateBio’s LinkedIn engagement rate to 8.3%, far surpassing the average of 0.05%. LinkedIn impressions soared by 1,030%, followers grew by 13.6%, and total engagements averaged a 2,615% increase, with an engagement rate per impression of 8.8%.